Results 161 to 170 of about 23,757 (245)

Utility of Urinary Extracellular Vesicles for Colorectal Cancer: Comparison of DNA Quality and MRD Detection

Cancer Science, Volume 117, Issue 6, Page 1667-1677, June 2026.
Urinary EVs provide highly pure vesicles with superior DNA quality, making them a robust and completely non‐invasive source for molecular profiling. Urinary EV‐DNA–based MRD assessment shows significant prognostic value and may serve as a practical tool for postoperative monitoring and risk stratification in colorectal cancer.
Shintaro Kanaka, Takeshi Yamada, Fumi Asai, Yuta Shimizu, Kay Uehara, Akihisa Matsuda, Seiichi Shinji, Yasuyuki Yokoyama, Goro Takahashi, Takuma Iwai, Kohki Takeda, Sho Kuriyama, Toshimitsu Miyasaka, Koki Hayashi, Hiroshi Yoshida   +14 more
wiley   +1 more source

Annual magnetic resonance cholangiopancreatography surveillance outcomes in individuals with primary sclerosing cholangitis

Internal Medicine Journal, Volume 56, Issue 6, Page 1026-1032, June 2026.
Abstract Background Annual surveillance for cholangiocarcinoma using magnetic resonance cholangiopancreatography (MRCP) has been recommended in primary sclerosing cholangitis (PSC) to improve the associated dismal outcomes. However, data are limited. Aims To compare the outcomes of surveillance versus non‐surveillance in patients with PSC.
Gary Dezhi Zhang, Chloe Attree, Nazneen Irani, Jonathan Tibballs, John Ferguson, Luis Calzadilla Bertot, Michael Wallace, Briohny Smith, George Garas, Gary Jeffrey, Leon Anton Adams, Gerry MacQuillan   +11 more
wiley   +1 more source

Pushing the boundaries of surgical resectability in colorectal liver metastases: the advancing role of two-stage hepatectomy. [PDF]

Hepatobiliary Surg Nutr
Knitter S, Krenzien F, Raschzok N, Pratschke J, Schöning W.   +4 more
europepmc   +1 more source

Intrahepatic Cholangiocarcinoma: Epidemiological Trends, Risk Factors, Diagnostic Challenges, and Advances in Personalized Therapy—A Comprehensive Review

Journal of Gastroenterology and Hepatology, Volume 41, Issue 6, Page 1701-1721, June 2026.
ABSTRACT Intrahepatic cholangiocarcinoma (iCCA) ranks as the second most common primary liver cancer, compared to about 20% of cases. Its global incidence has climbed over the past four decades, yet early detection remains indefinable due to its asymptomatic nature. Five‐year survival rate of approximately is under 10%.
Yaqoob Muhammad, YuZhu Jin, Kai Luo, He Bai, Xudong Zhang, Xu Sun, Zahoor Maheen, Ali Tanveer, Saeed Muddasar Muhammad, Jialin Qu, Guixin Zhang   +10 more
wiley   +1 more source

Revisiting the two-stage hepatectomy and hepatic arterial infusion chemotherapy for colorectal liver metastases: insights and long-term outcomes from a large cohort. [PDF]

Hepatobiliary Surg Nutr
Vandaele T, D'Hondt M.
europepmc   +1 more source

Stage-by-stage analysis of the effect of blood transfusion on survival after curative hepatectomy for hepatocellular carcinoma—a retrospective study

ObjectiveThis study is to examine the impact of perioperative (intraoperative/postoperative) blood transfusion on the outcomes of curative hepatectomy for hepatocellular carcinoma.Summary background dataHepatectomy is a well-established curative ...
Lo, Chung Mau, Chan, Albert Chi Yan, Cheung, Tan To, Tsang, Simon Hing Yin, She, Wong Hoi, Dai, Wing Chiu   +5 more
core   +1 more source

Prognostic Value of Pathological Response After Conversion Therapy and Salvage Surgery in Unresectable Hepatocellular Carcinoma

Liver International, Volume 46, Issue 6, June 2026.
ABSTRACT Background and Aims To evaluate the prognostic significance of pathological response in patients with initially unresectable hepatocellular carcinoma (uHCC) who underwent salvage resection after successful conversion with lenvatinib, anti‐PD‐1 antibodies, and locoregional therapy (LPLRT).
Qi‐Yu Chi, Xiao‐Di Gao, Mi Wang, Quan‐Yuan Liu, Yong‐Yi Zeng, Lan‐Fang Yang, Zi‐Jian Liu, Shuang‐Jia Wang, Shan‐Geng Weng, Zhi‐Bo Zhang   +9 more
wiley   +1 more source

Massive Hepatocellular Carcinoma with Insufficient Future Liver Remnant Achieved Complete Response After Two-Stage Hepatectomy Combined with Hepatic Arterial Infusion Chemotherapy and Lenvatinib-sintilimab: A Case Report. [PDF]

Pharmgenomics Pers Med
Xu R, Zhang M, Zeng Z, Wei Y, Liao X, Yang C, Peng T, Su H.   +7 more
europepmc   +1 more source

Effectiveness of Minimally Invasive Hepatectomy in Patients with Early or Intermediate-Stage Hepatocellular Carcinoma: A Multi-Institutional Cohort Study in an Asian Population

Hung-Kai Chen,1– 3,* Kai-Cheng Chang,3,4,* Shih-Chieh Shao,4– 6 Ruey-Shyang Soong,7– 9 Yi-Chan Chen,10,11 Chun-Feng Wu,12 Tsung-Han Wu,12 Tien-Shin Chou,13 Siu-Cheung Chan,14 Edward Chia-Cheng Lai4,6 1Department of Pharmaceutical Outcomes
Chen YC, Chang KC, Soong RS, Wu TH, Shao SC, Wu CF, Chan SC, Chen HK, Chou TS, Lai ECC   +9 more
core  

Risk Factors for Dysfunctional Liver Graft Response: A Case–Control Study

Nursing &Health Sciences, Volume 28, Issue 2, June 2026.
ABSTRACT The purpose of this article was to identify recipient‐, donor‐, and graft‐related risk factors associated with dysfunctional liver graft response following liver transplantation. A case–control study was developed based on medical records of adult liver transplant recipients were analyzed.
Layana de Paula Cavalcante, João Cruz Neto, Maria Beatriz Freire Alves, Francisca Alessandra Peixoto da Cunha, Ana Clara de Brito Gomes, Reinaldo Gutierrez Barreiro, Viviane Martins da Silva, Marcos Venícios de Oliveira Lopes   +7 more
wiley   +1 more source